Carbonylative transformation of aryl halides and strong bonds via cheap metal catalysts and sustainable technologies.

Autor: Maolin Yang¹, Yukun Liu¹, Xin Qi², Yanhua Zhao¹, Xiao-Feng Wu^1,2 Xiao-Feng.Wu@catalysis.de

Publikováno v: Green Synthesis & Catalysis. Nov2024, Vol. 5 Issue 4, p211-269. 59p.

Discovery and SAR Studies of Potent Modulators of BMI‐1 Expression.

Autor: Baiazitov, Ramil Y.¹ (AUTHOR) rbaiazitov@ptcbio.com, Sydorenko, Nadiya¹ (AUTHOR), Du, Wu² (AUTHOR), Ren, Hongyu¹ (AUTHOR), Cao, Liang¹ (AUTHOR), Davis, Thomas³ (AUTHOR), Cintron‐Lue, Katherine¹ (AUTHOR), Kim, Min‐Jung¹ (AUTHOR), Zhuo, Jin¹ (AUTHOR), Mody, Shreshtha¹ (AUTHOR), Weetall, Marla¹ (AUTHOR), Sheedy, Josephine¹ (AUTHOR), Risher, Nicole¹ (AUTHOR), Almstead, Neil⁴ (AUTHOR), Moon, Young‐Choon¹ (AUTHOR)

Publikováno v: Helvetica Chimica Acta. Sep2023, Vol. 106 Issue 9, p1-17. 17p.

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

Autor: D D, Richman, M A, Fischl, M H, Grieco, M S, Gottlieb, P A, Volberding, O L, Laskin, J M, Leedom, J E, Groopman, D, Mildvan, M S, Hirsch

Publikováno v: The New England journal of medicine. 317(4)

We conducted a double-blind, placebo-controlled trial of oral azidothymidine (AZT) in 282 patients with the acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. Although significant clinical benefit was documented (N Engl J Med 1987; 31

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::efc7bb2f90c1b31816777fb127074672
https://pubmed.ncbi.nlm.nih.gov/3299090

Therapy of herpes zoster with oral acyclovir

Autor: J C, Huff, B, Bean, H H, Balfour, O L, Laskin, J D, Connor, L, Corey, Y J, Bryson, P, McGuirt

Publikováno v: The American journal of medicine. 85(2A)

Oral acyclovir therapy for herpes zoster has been studied in double-blind, placebo-controlled trials of two dosages, 400 mg and 800 mg five times per day for 10 days. Compared with placebo recipients, recipients of the high-dosage acyclovir experienc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::13977d23816ed3e133d7bcd45c43607e
https://pubmed.ncbi.nlm.nih.gov/3044099

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

Autor: M A, Fischl, D D, Richman, M H, Grieco, M S, Gottlieb, P A, Volberding, O L, Laskin, J M, Leedom, J E, Groopman, D, Mildvan, R T, Schooley

Publikováno v: The New England journal of medicine. 317(4)

We conducted a double-blind, placebo-controlled trial of the efficacy of oral azidothymidine (AZT) in 282 patients with the acquired immunodeficiency syndrome (AIDS) manifested by Pneumocystis carinii pneumonia alone, or with advanced AIDS-related co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::dcdc9c3377c092598236d669c1531b09
https://pubmed.ncbi.nlm.nih.gov/3299089